GNNSF - Twist Bioscience: New Profitability Oriented Management & Direction Compensates For The 435% Share-Premium
Graphic Source: Twist Bioscience Corporation
Introduction: What is Twist Biosciences?
Twist Bioscience Corporation (TWST) is a high-growth synthetic biology company that launched a uniquely low-cost DNA synthesis platform in 2016 based on proprietary silicon chip DNA writing. This has since been leveraged to produce a wider-range of synthetic DNA-based products. Founded in 2013 with commercial operations beginning in 2016, TWST has since grown to revenues of $54M (2019) with over 400 employees across offices in CA-USA and Israel.
Products: TWST's main products include Synthetic Genes (3Q: 46% of revenues), Next Generation Sequencing tools (41%), DNA